These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25580924)

  • 21. Evaluating depression and suicidality in tetrabenazine users with Huntington disease.
    Schultz JL; Killoran A; Nopoulos PC; Chabal CC; Moser DJ; Kamholz JA
    Neurology; 2018 Jul; 91(3):e202-e207. PubMed ID: 29925548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic use of tetrabenazine].
    López Del Val LJ; López-García E; Martínez-Martínez L; Santos-Lasaosa S
    Rev Neurol; 2009 May 16-31; 48(10):523-33. PubMed ID: 19434587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of chorea associated with Huntington's disease: focus on tetrabenazine.
    Setter SM; Neumiller JJ; Dobbins EK; Wood L; Clark J; DuVall CA; Santiago A
    Consult Pharm; 2009 Jul; 24(7):524-37. PubMed ID: 19689181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
    Huntington Study Group
    Neurology; 2006 Feb; 66(3):366-72. PubMed ID: 16476934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Huntington disease: tetrabenazine compared to haloperidol in the reduction of involuntary movements].
    Giménez-Roldán S; Mateo D
    Neurologia; 1989 Oct; 4(8):282-7. PubMed ID: 2534679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term treatment of tardive dyskinesia with presynaptically acting dopamine-depleting agents.
    Fahn S
    Adv Neurol; 1983; 37():267-76. PubMed ID: 6858776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.
    Frank S; Stamler D; Kayson E; Claassen DO; Colcher A; Davis C; Duker A; Eberly S; Elmer L; Furr-Stimming E; Gudesblatt M; Hunter C; Jankovic J; Kostyk SK; Kumar R; Loy C; Mallonee W; Oakes D; Scott BL; Sung V; Goldstein J; Vaughan C; Testa CM;
    JAMA Neurol; 2017 Aug; 74(8):977-982. PubMed ID: 28692723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid improvement of tardive dyskinesia with tetrabenazine, clonazepam and clozapine combined: a naturalistic long-term follow-up study.
    Kimiagar I; Dobronevsky E; Prokhorov T; Miniovitz A; Rabey JM
    J Neurol; 2012 Apr; 259(4):660-4. PubMed ID: 22068977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of myoclonus-dystonia syndrome with tetrabenazine.
    Luciano AY; Jinnah HA; Pfeiffer RF; Truong DD; Nance MA; LeDoux MS
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1423-6. PubMed ID: 25406829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of weight gain in treatments for Tourette syndrome: tetrabenazine versus neuroleptic drugs.
    Ondo WG; Jong D; Davis A
    J Child Neurol; 2008 Apr; 23(4):435-7. PubMed ID: 18192650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An experimental model for Huntington's chorea?
    Zeef DH; Jahanshahi A; Vlamings R; Casaca-Carreira J; Santegoeds RG; Janssen ML; Oosterloo M; Temel Y
    Behav Brain Res; 2014 Apr; 262():31-4. PubMed ID: 24412685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-traumatic tics and tetrabenazine treatment: a blinded video assessment.
    Poulopoulos M; Hajjar M
    BMJ Case Rep; 2013 Dec; 2013():. PubMed ID: 24311459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postthalamic stroke dystonic choreoathetosis responsive to tetrabenazine.
    Calabrò RS; Polimeni G; Gervasi G; Bramanti P
    Ann Pharmacother; 2011 Dec; 45(12):e65. PubMed ID: 22116988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine.
    Skor H; Smith EB; Loewen G; O'Brien CF; Grigoriadis DE; Bozigian H
    Drugs R D; 2017 Sep; 17(3):449-459. PubMed ID: 28776237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tetrabenazine in treatment of hyperkinetic movement disorders: an observational study.
    Miguel R; Mendonça MD; Barbosa R; Ladeira F; Lampreia T; Vale J; Bugalho P
    Ther Adv Neurol Disord; 2017 Feb; 10(2):81-90. PubMed ID: 28382107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
    Guay DR
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):331-73. PubMed ID: 20869622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of tetrabenazine use on restless legs syndrome.
    Ondo WG; Jia JJ
    Sleep Med; 2010 Oct; 11(9):958-9. PubMed ID: 20817597
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of tetrabenazine on methamphetamine-induced hyperactivity in mice are dependent on order and time-course of administration.
    Kuribara H
    Pharmacol Biochem Behav; 1997 Jan; 56(1):9-14. PubMed ID: 8981603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification and treatment of tardive syndromes.
    Fernandez HH; Friedman JH
    Neurologist; 2003 Jan; 9(1):16-27. PubMed ID: 12801428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tetrabenazine treatment for stereotypies and tics associated with dementia.
    Ondo WG
    J Neuropsychiatry Clin Neurosci; 2012; 24(2):208-14. PubMed ID: 22772669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.